NCT03854032 2025-06-06Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and NeckThomas Jefferson UniversityPhase 2 Active not recruiting45 enrolled
NCT03162731 2025-04-29Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck CancerThomas Jefferson UniversityPhase EARLY_PHASE1 Completed24 enrolled